Postmenopausal Hormone Therapy and the Risks of Coronary Heart Disease, Breast Cancer, and Stroke

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Seminars in Reproductive Medicine

• Publication date

  2014-10-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0034-1384624PMID 25321418PMCID PMC4212810
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects

  2014cited by this paper
• Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.

  2013cited by this paper
• Estrogen plus progestin and colorectal cancer incidence and mortality.

  2012cited by this paper
• Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk

  2012cited by this paper
• Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy

  2011cited by this paper
• Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial.

  2011cited by this paper
• Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior Hysterectomy: A Randomized Controlled Trial

  2011cited by this paper
• Genetic variants in the MRPS30 region and postmenopausal breast cancer risk

  2011cited by this paper
• Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling

  2010cited by this paper
• Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.

  2010cited by this paper
• The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women

  2010cited by this paper
• Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings

  2009cited by this paper
• Postmenopausal estrogen and progestin effects on the serum proteome

  2009cited by this paper
• Variation in the FGFR2 Gene and the Effects of Postmenopausal Hormone Therapy on Invasive Breast Cancer

  2009cited by this paper
• Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.

  2009cited by this paper
• Breast cancer after use of estrogen plus progestin in postmenopausal women.

  2009cited by this paper
• Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin

  2009cited by this paper
• The women's health initiative: lessons learned.

  2008cited by this paper
• Conjugated Equine Estrogens and Colorectal Cancer Incidence and Survival: The Women's Health Initiative Randomized Clinical Trial

  2008cited by this paper
• Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study.

  2008cited by this paper
• Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.

  2008cited by this paper
• Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.

  2008cited by this paper
• Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy.

  2008cited by this paper
• Can Biomarkers Identify Women at Increased Stroke Risk? The Women's Health Initiative Hormone Trials

  2007cited by this paper
• The decrease in breast-cancer incidence in 2003 in the United States.

  2007cited by this paper
• Faculty Opinions recommendation of Venous thrombosis and conjugated equine estrogen in women without a uterus.

  2006cited by this paper
• Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.

  2006cited by this paper
• Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.

  2006cited by this paper
• Effect of Estrogen Therapy on Gallbladder Disease

  2006cited by this paper
• Effects of Conjugated Equine Estrogen on Stroke in the Women’s Health Initiative

  2006cited by this paper
• Conjugated equine estrogens and peripheral arterial disease risk: the Women's Health Initiative.

  2006cited by this paper
• The effect of conjugated equine oestrogen on diabetes incidence: the Women’s Health Initiative randomised trial

  2006cited by this paper
• Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

  2006cited by this paper
• Effects of Conjugated Equine Estrogen on Risk of Fractures and BMD in Postmenopausal Women With Hysterectomy: Results From the Women's Health Initiative Randomized Trial

  2006cited by this paper
• Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.

  2005cited by this paper
• Effects of estrogen with and without progestin on urinary incontinence.

  2005cited by this paper
• Estrogen plus progestin and risk of venous thrombosis.

  2005cited by this paper
• Estrogen plus progestin and colorectal cancer in postmenopausal women.

  2004cited by this paper
• Estrogen Plus Progestin and the Risk of Peripheral Arterial Disease: The Women’s Health Initiative

  2004cited by this paper
• National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section

  2004cited by this paper
• Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study

  2004cited by this paper
• Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women’s Health Initiative Hormone Trial

  2004cited by this paper
• Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

  2004cited by this paper
• Estrogen plus progestin and risk of venous thrombosis.

  2004cited by this paper
• Estrogen plus progestin and colorectal cancer in postmenopausal women.

  2004cited by this paper
• Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence.

  2004cited by this paper
• Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.

  2003cited by this paper
• Breast cancer and hormone-replacement therapy in the Million Women Study.

  2003cited by this paper
• Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.

  2003cited by this paper
• Breast cancer and hormone-replacement therapy: the Million Women Study.

  2003cited by this paper
• Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

  2003cited by this paper
• Breast cancer and hormone-replacement therapy in the Million Women Study.

  2003cited by this paper
• Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.

  2003cited by this paper
• Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

  2003cited by this paper
• Estrogen plus progestin and the risk of coronary heart disease.

  2003cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

  1998cited by this paper
• Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial

  1995cited by this paper
• Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.

  1995cited by this paper
• Inflammatory, Lipid, Thrombotic, and Genetic Markers of Coronary Heart Disease Risk in the Women's Health Initiative Trials of Hormone Therapy

  year unknowncited by this paper

• A Mixture of Cervus elaphus sibiricus and Glycine max (L.) Merrill Inhibits Ovariectomy-Induced Bone Loss Via Regulation of Osteogenic Molecules in a Mouse Model

  2023cites this paper
• Anti-Osteoporosis Effects of the Fruit of Sea Buckthorn (Hippophae rhamnoides) through Promotion of Osteogenic Differentiation in Ovariectomized Mice

  2022cites this paper
• Lactation Duration and the Risk of Subtypes of Stroke Among Parous Postmenopausal Women From the China Kadoorie Biobank

  2022cites this paper
• Hand Osteoarthritis: investigating Pain Effects of estrogen-containing therapy (HOPE-e): a protocol for a feasibility randomised placebo-controlled trial

  2021cites this paper
• Suppressive role of Viola odorata extract on malignant characters of mammosphere-derived breast cancer stem cells

  2020cites this paper
• Menopausal Hot Flashes, Sleep and Mood Disturbances

  2019cites this paper
• Osteopenia-osteoporosis discrimination in postmenopausal women by 1H NMR-based metabonomics

  2019cites this paper
• Evaluation of Fractional CO 2 Laser Treatment Efficacy and Comparison to Vaginal Conjugated Estrogen Cream in Postmenopausal Women with Vulvovaginal Atrophy : A Randomized Clinical Trial

  2019cites this paper
• Equol Decreases Hot Flashes in Postmenopausal Women: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

  2019cites this paper
• A Multicenter, Randomized, Controlled Trial of Electroacupuncture for Perimenopause Women with Mild-Moderate Depression

  2018cites this paper
• Exogenous reproductive hormone use in breast cancer survivors and previvors

  2018cites this paper
• Relative Effectiveness in Breast Cancer Treatment : A Health Production Approach

  2018cites this paper
• Enzyme linked immunosorbent assay for total potent estrogenic miroestrol and deoxymiroestrol of Pueraria candollei, a Thai herb for menopause remedy

  2018cites this paper
• Estrogen Interactions With Lipid Rafts Related to Neuroprotection. Impact of Brain Ageing and Menopause

  2018cites this paper
• Protective Effects of 2,3,5,4′-Tetrahydroxystilbene-2-O-β-d-glucoside on Ovariectomy Induced Osteoporosis Mouse Model

  2018cites this paper
• Use of cardiovascular age for assessing risks and benefits of menopausal hormone therapy

  2017cites this paper
• Mitochondrial function in hypoxic ischemic injury and influence of aging

  2017cites this paper
• Blood Serum Atherogenicity: Cellular Test for the Development of Anti- Atherosclerotic Therapy.

  2017cites this paper
• Effect of ovariectomy and Sideritis euboea extract administration on large artery mechanics, morphology, and structure in middle-aged rats

  2017cites this paper
• Giving another chance to mifepristone in pharmacotherapy for aggressive meningiomas-A likely synergism with hydroxyurea?

  2016cites this paper
• Treatment with aromatase inhibitors and markers of cardiovascular disease

  2016cites this paper
• Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery

  2016influential citation
• Association of Mid-Life Changes in Body Size, Body Composition and Obesity Status with the Menopausal Transition

  2016cites this paper
• Cellular Model of Atherogenesis Based on Pluripotent Vascular Wall Pericytes

  2016cites this paper
• Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study

  2016cites this paper
• Adolescent Menstrual Management: The Complex Intersection of Science, Patient Autonomy, and Reproductive Justice

  2016cites this paper
• 5. Cellular cholesterol retention in atherosclerosis and direct anti-atherosclerosis therapy

  2016cites this paper
• Influencia del consumo de antiinflamatorios no esteroideos en la incidencia de cáncer de mama: = Influence of non-streroidal antiinflammatory drugs use on breast cancer incidence

  2015influential citation
• RELATIVE EFFECTIVENESS IN BREAST CANCER TREATMENT: A HEALTH PRODUCTION APPROACH

  2015cites this paper
• Emerging Vascular Risk Factors in Women: Any Differences from Men?

  2015cites this paper
• The Availability of Beneficial Insects-originated Materials on Women's Health following Menopause

  2015cites this paper
• Endometriosis and breast cancer: A survey of the epidemiological studies

  2015cites this paper
• A Placebo-Controlled Study of Raloxifene Added to Risperidone in Men with Chronic Schizophrenia.

  2015cites this paper